31Indexed trials
mesh condition
Neuralgia
Intelligence
Neuralgia intelligence: 31 indexed trials, 6 recruiting studies, 29 sponsors across 27 countries.
6Recruiting
29Sponsors
27Countries
Leading sponsors
Second Affiliated Hospital, Zhejiang University, School of Medicine21 recruiting
GlaxoSmithKline20 recruiting
Biohaven Therapeutics Ltd.10 recruiting
Bristol-Myers Squibb10 recruiting
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)10 recruiting
Daiichi Sankyo10 recruiting
Fondation Hôpital Saint-Joseph11 recruiting
Eli Lilly and Company10 recruiting
Fondation Ophtalmologique Adolphe de Rothschild10 recruiting
Bioness Inc10 recruiting
InSightec11 recruiting
Assistance Publique Hopitaux De Marseille11 recruiting
Geographic activity
United States11trials
Canada4trials
France3trials
China3trials
India2trials
Taiwan2trials
Turkey (Türkiye)2trials
Poland2trials
Denmark1trials
Italy1trials
Czechia1trials
Israel1trials
Leading interventions
Gabapentin prescriptions2trials
pregabalin2trials
Gabapentin2trials
BHV-70001trials
Conventional Physical therapy1trials
Conventional physical therapy program1trials
Bilateral ophthalmologic examination1trials
Diphenhydramine1trials
Duloxetine1trials
Far-Infrared Radiation (FIR) Socks1trials
DS-1971a1trials
BMS-7416721trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.